Metformin for asthma in overweight adults
Part of Hormones & metabolism, Immune system & allergy, Lungs & breathing clinical trials.
This trial tests whether the diabetes drug metformin can help people with asthma who are also overweight or obese. The goal is to see if it improves asthma control and reduces the need for rescue medications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have asthma that is not well controlled, even with your regular medications.
- You are overweight or obese (BMI of 25 or higher).
- You are 18 years old or older.
- You are not pregnant, planning to become pregnant, or breastfeeding.
- You do not have serious heart, kidney, liver, or lung disease, or diabetes.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether taking a chromium supplement can help people with asthma who are also obese. It looks at whether the supplement helps you lose weight and improves your asthma control, since weight loss often makes breathing easier.
This study looks at how weight and blood-sugar/fat changes in the body may affect the airways in people with asthma. You may be asked to complete breathing tests and possibly an airway procedure (bronchoscopy) to help researchers compare groups.
This study tests if metformin, a medicine used for diabetes, can help improve asthma control in children who are overweight or obese. It aims to see if adding metformin to standard asthma treatment helps reduce symptoms and improve quality of life.
This trial tests whether metformin, a common diabetes medicine, can help people with obesity lose weight. It is for people who do not have diabetes and have not used weight loss treatments in the past year.
This trial tests whether adding metformin (a diabetes medicine) to usual antidepressant treatment can help improve depression in people who are overweight or obese. It is for adults age 18–44 who are newly diagnosed with depression and do not have diabetes.
This study tests whether metformin, a common diabetes drug, can slow down the aging of the lungs and improve COPD symptoms. If you have COPD and meet the specific lung function and smoking history criteria, you might be able to join.
Hear when a new Asthma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.